Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

Tracy Murphy, Jacqueline M. Mason, Brian Leber, Mark R. Bray, Steven M. Chan, Vikas Gupta, Dina Khalaf, Dawn Maze, Caroline McNamara, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W. Mak, Mark D. Minden, Karen Yee